JENNA COAKLEY: Open Payments
NPI 1932815453 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 67 payments from 15 companies in 2025. Trend: 2023 $1,874 · 2024 $1,063 · 2025 $1,716
Food & beverage: $1,708Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $517 |
| GENZYME CORPORATION | 16 | $381 |
| Janssen Biotech, Inc. | 20 | $376 |
| Incyte Corporation | 3 | $154 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Botanix SB Inc | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Almirall LLC | 1 | $25 |
| UCB, Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
Products named: DUPIXENT, TREMFYA, RINVOQ, OPZELURA, SKYRIZI, LIBTAYO, SOFDRA, COSENTYX.
Industry payments across SC — which companies pay providers there.
